You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MDGL Sale Disclosure
Sibold William John · SEC Form 4 · Filed Jul 20, 2026
Sale
Calculated transaction value
$296.87K
Sibold William John President And CEO
MDGL
Transaction date
Jul 20, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed same day
MDGL daily price context
Close on/before transaction
$535.69
Jul 20, 2026
First close after public filing
$546.79
Jul 21, 2026
30-day return after filing
-1.21%
Through Aug 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 545 shares @ $544.71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-048919
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.37M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $25.8K |
| Madrigal Pharmaceuticals, Inc. MDGL Current | Sale | Jul 20, 2026 | $296.87K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $59.82K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $550.72 |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $147.16K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $372.43K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $84.15K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $75.98K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $155.41K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $150.07K |
| Madrigal Pharmaceuticals, Inc. MDGL | Exercise | Jul 17, 2026 | $0 |
| Madrigal Pharmaceuticals, Inc. MDGL | Exercise | Jul 17, 2026 | Not reported |